Aceragen Announces Acquisition of Arrevus, Expands Late-Stage Rare Disease Pipeline

NEXT STORY
7 Hills Pharma Announces the Completion of a Landmark Phase I Trial of Immunostimulant to Improve Immuno-Oncology Drugs, COVID-19 and Influenza Vaccines
PREV STORY
PharmaTher Provides Research Update on Microneedle Patch Delivery Technologies for Psychedelics
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Bellerophon Therapeutics Submits Investigational New Drug Application to Study INOpulse® Inhaled Nitric Oxide Therapy for the Treatment of COVID-19

author_avatar
NASDAQ Market News

VBI Vaccines Announces Closing of Public Offering and Concurrent Registered Direct Offering of Common Shares

CAMBRIDGE, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (TSX:VBV) (VBI), ...

author_avatar
NASDAQ Market News

Onconova Announces First Patient Dosed in Investigator-Initiated Phase 2 Study of Rigosertib in Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma

author_avatar
NASDAQ Market News